HOME > 研究業績詳細

研究業績詳細

久保原 禅(クボハラ ユズル)

研究テーマ 新規な抗腫瘍剤/糖尿病治療薬/免疫制御剤/抗トリパノソーマ剤/抗マラリア剤/抗菌剤などの開発、細胞分化/細胞運動の機構解析
研究業績(論文) #研究業績の詳細は研究室HP: http://square.umin.ac.jp/jun_health_LS/index.html

<原著論文(2010年以降)> 責任著者*
Kubohara Y*, Fukunaga Y, Shigenaga A, & Kikuchi H.
Dictyostelium differentiation-inducing factor 1 promotes glucose uptake via direct inhibition of mitochondrial malate dehydrogenase in mouse 3T3-L1 cells.
Int. J. Mol. Sci. 25(3), 1889. (2024). Invited.

Kubohara Y*, Fukunaga Y, Kikuchi H, & Kuwayama H.
Pharmacological evidence that Dictyostelium differentiation-inducing factor 1 promotes glucose uptake partly via an increase in intracellular cAMP content in mouse 3T3-L1 cells.
Molecules, 28(23), 7926. (2023). Invited.

Kuwayama H, Kikuchi H, & Kubohara Y*.
Derivatives of differentiation-inducing factor 1 differentially control chemotaxis and stalk cell differentiation in Dictyostelium discoideum.
Biology, 12, 873 (2023). Invited.

Hirayama A, Ishigaki H, Takahashi K, Miura Y, Kikuchi H, & Kubohara Y*.
Dictyostelium differentiation-inducing factor derivatives reduce the glycosylation of PD-L1 in MDA-MB-231 human breast cancer cells.
Juntendo Medical J. 69, 105-115, (2023).

Mita T*, Hirai M, Maki Y, Nahar S, Ikeda M, Yoshida N, Oshima Y, Kikuchi H, & Kubohara Y*.
Derivatives of Dictyostelium differentiation-inducing factors suppress the growth of Plasmodium parasites in vitro and in vivo.
Biochem. Pharmacol. 194, 114834. (2021).
#本研究成果は順天堂大学よりプレスリリース(2021年12月2日):
https://www.juntendo.ac.jp/news/20211202-02.html

Kubohara Y*, Homma Y, Shibata H, Oshima Y, Kikuchi H.
Dictyostelium differentiation-inducing factor-1 promotes glucose uptake, at least in part, via an AMPK-dependent pathway in mouse 3T3-L1 cells.
Int. J. Mol. Sci. 22(5), 2293. (2021).

Sasaki H, Kubohara Y, Ishigaki H, Takahashi K, Eguchi H, Sugawara A, Oshima Y, & Kikuchi H*.
Novel two terpenes isolated from Dictyostelium cellular slime molds.
Molecules, 25(12), 2895. (2020).

Totsuka K, Makioka Y, Iizumi K, Takahashi K, Oshima Y, Kikuchi H*, & Kubohara Y*.
Halogen-substituted derivatives of Dictyostelium differentiation-inducing factor-1 suppress serum-induced cell migration of human breast cancer MDA-MB-231 cells in vitro.
Biomolecules 9(7), 256. (2019).

Fujita K, Tanaka S, Iizumi K, Akiyama S, Uchida K, Ogata M, Aoki D, Hosomi O*, & Kubohara Y*.
Melibiosamine, a novel oligosaccharide, suppresses mitogen-induced IL-2 production via inactivation of NFAT and NFκB in Jurkat cells.
Biochem. Biophys. Rep. 19, 100658. (2019).

Kubohara Y*, Shiratsuchi Y, Ishigaki H, Takahashi K, Oshima Y, & Kikuchi H.
Antimicrobial activities of Dictyostelium differentiation-inducing factors and their derivatives.
Biomolecules 9(5), 163. (2019).

Kubohara Y*, Kikuchi H, & Oshima Y.
Derivatives of Dictyostelium differentiation-inducing factors inhibit serum-dependent cell migration of murine osteosarcoma LM8 cells.
Juntendo Med. J. 65(1), 71–76.(2019).

Kubohara Y*, & Kikuchi H.
Dictyostelium: an important source of structural and functional diversity in drug discovery. (Review)
Cells 8(1), 6. (2019). Invited.

Takahashi K, Kikuchi H*, Nguyen VH, Oshima Y, Ishigaki H, Nakajima-Shimada J, & Kubohara Y*.
Biological activities of novel derivatives of differentiation-inducing factor-3 from Dictyostelium discoideum.
Biol. Pharm. Bull. 40(11), 1941-1947. (2017).

Kikuchi H*, Ito I, Takahashi K, Ishigaki H, Iizumi K, Kubohara Y, & Oshima Y.
Isolation, synthesis and biological activity of chlorinated alkylresorcinols from Dictyostelium cellular slime molds.
J. Nat. Prod. 80(10), 2716-2722. (2017).

Nguyen VH, Kikuchi H*, Sasaki H, Iizumi K, Kubohara Y, & Oshima Y*.
Production of novel bispyrone metabolites in the cellular slime mold Dictyostelium giganteum induced by zinc(II) ion.
Tetrahedron 73(5), 583-588. (2017).

Kubohara Y*, Kikuchi H, Nguyen VH, Kuwayama H, & Oshima Y.
Evidence that differentiation-inducing factor-1 controls chemotaxis and cell differentiation, at least in part, via mitochondria in D. discoideum.
Biology Open, 6, 741-751. (2017).

Kuwayama H, & Kubohara Y*.
Differentiation-inducing factor 2 modulates chemotaxis via the histidine kinase DhkC-dependent pathway in Dictyostelium discoideum.
FEBS Lett. 590(6), 760-768. (2016).

Kawaharada R, Nakamura A, Takahashi K, Kikuchi H, Oshima Y, & Kubohara Y*.
Oral administration of Dictyostelium differentiation-inducing factor 1 lowers blood glucose levels in streptozotocin-induced diabetic rats.
Life Sciences 155, 56-62. (2016).

Zhang J*, Yamada O*, Kida S, Matsushita Y, Murase S, Hattori T, Kubohara Y, Kikuchi H, & Oshima Y.
Identification of brefelamide as a novel inhibitor of osteopontin that suppresses invasion of A549 lung cancer cells.
Oncol. Rep. 36, 2357-2364. (2016).

Kuwayama H, Kikuchi H, Oshima Y, & Kubohara Y*.
Glutathione S-transferase 4 is a putative DIF-binding protein that regulates the size of fruiting bodies in Dictyostelium discoideum.
Biochem. Biophys. Rep. 8, 219-226. (2016).

Kubohara Y*, Komachi M, Homma Y, Kikuchi H, & Oshima Y.
Derivatives of Dictyostelium differentiation-inducing factors inhibit lysophosphatidic acid–stimulated migration of murine osteosarcoma LM8 cells.
Biochem. Biophys. Res. Commun. 463(4), 800-805. (2015).

Nguyen VH, Kikuchi H*, Kubohara Y, Takahashi K, Katou Y, & Oshima Y*.
Development of novel DIF-1 derivatives that selectively suppress innate immune responses.
Bioorg. Med. Chem. 23(15), 4311-4315. (2015).

Oladimeji P, Kubohara Y, Kikuchi H, Oshima Y, Rusch C, Skerl R, & Diakonova M*.
A Derivative of Differentiation-Inducing Factor-3 Inhibits PAK1 Activity and Breast Cancer Cell Proliferation.
Int. J. Cancer Clin. Res. 2, 3. (2015).

Kubohara Y*, Kikuchi H, Matsuo Y, Oshima Y, & Homma Y.
Properties of a non-bioactive fluorescent derivative of differentiation-inducing factor-3, an anti-tumor agent found in Dictyostelium discoideum.
Biology Open 3(4), 289-296. (2014).

Nakajima-Shimada J*, Hatabu T, Hosoi Y, Onizuka Y, Kikuchi H, Oshima Y, & Kubohara Y*.
Derivatives of Dictyostelium discoideum differentiation-inducing factor-3 suppress the activities of Trypanosoma cruzi in vitro and in vivo.
Biochem. Pharmacol. 85, 1603-1610. (2013).

Kikuchi H*, Kubohara Y, Hai VN, Katou Y, & Oshima Y.
Novel chlorinated dibenzofurans Isolated from the cellular slime mold, Polysphondylium filamentosum, and their biological activities.
Bioorg. Med. Chem. 21, 4628-4633. (2013).

Yamada Y, Kubohara Y, Kikuchi H, Oshima Y, Wang HY, Ross S, & Williams JG*.
The Dictyostelium prestalk inducer DIF-1 directs phosphorylation of a bZIP transcription factor.
Int. J. Dev. Biol. 57, 375-381. (2013).

Kubohara Y*, Kikuchi H, Matsuo Y, Oshima Y, & Homma Y.
Mitochondria are the target organelle of differentiation-inducing factor-3, an anti-tumor agent isolated from Dictyostelium discoideum.
PLoS ONE 8, e72118. (2013).

Seya K*, Kanemaru K, Matsuki M, Hongo K, Kitahara H, Kikuchi H, Oshima Y, Kubohara Y, Okumura K, Motomura S, & Furukawa K.
Br-DIF-1 accelerates dimethyl sulphoxide-induced differentiation of P19CL6 embryonic carcinoma cells into cardiomyocytes.
Brit. J. Pharmacol. 165, 870-879. (2012).

Tanaka S, Masuda Y, Honma C, Hosaka K, Takahashi K, & Kubohara Y*.
Manganese promotes phorbol ester–induced interleukin-2 production via AP-1 activation in Jurkat T-cells.
Toxicol. Lett. 211(3), 312-318. (2012).

Kikuchi H*, Matsuo Y, Katou Y, Kubohara Y, & Oshima Y.
Isolation, synthesis and biological activity of biphenyl and m-terphenyl-type compounds from Dictyostelium cellular slime molds.
Tetrahedron 68, 8884-8889. (2012).

Takahashi K, Murakami M, Kikuchi H, Oshima Y, & Kubohara Y*.
Derivatives of Dictyostelium differentiation-inducing factors promote mitogen-activated IL-2 production via AP-1 in Jurkat cells.
Life Sciences 88, 480-485. (2011).

Kuwayama H, Kikuchi H, Oshima Y, & Kubohara Y*.
Artificial compounds differentially control Dictyostelium chemotaxis and cell differentiation.
Cell Structure and Function 36, 21-26. (2011).

Luciani M-F, Giusti C, Harms B, Oshima Y, Kikuchi H, Kubohara Y, & Golstein P*.
Atg1 allows second-signalled autophagic cell death in Dictyostelium.
Autophagy 7, 501-508. (2011).

Kubohara Y*, Kikuchi H, Nakamura K, Matsuo Y, & Oshima Y.
Preparation of an antibody that recognizes and neutralizes Dictyostelium differentiation-inducing factor-1.
Biochem. Biophys. Res. Commun. 396, 364-369. (2010).

Matsuda T, Takahashi-Yanaga F*, Yoshihara T, Maenaka K, Watanabe Y, Miwa Y, Morimoto S, Kubohara Y, Hirata M, & Sasaguri T.
Dictyostelium differentiation-inducing factor-1 binds to mitochondrial malate dehydrogenase and inhibits its activity.
J. Pharmacol. Sci. 112, 320-326. (2010).

Kikuchi H*, Ishiko S, Nakamura K, Kubohara Y, & Oshima Y*.
Novel prenylated and geranylated aromatic compounds isolated from Polysphondylium cellular slime molds.
Tetrahedron 66, 6000-6007. (2010).

Calvo-Garrido J, Carilla-Latorre S, Kubohara Y, Santos N, Mesquita A, Soldati T, Golstein P, & Escalante R*.
Autophagy in Dictyostelium: genes and pathways, cell death and infection. (Review)
Autophagy 6, 686-701. (2010).

<和文論文・総説>(2010年以降)
飯泉恭一*、重永綾子、都築孝允、川崎広明、山倉文幸、久保原禅
炎症性腸疾患の制御に関わる分子の探索-動物モデルを用いた運動の効果-
東北女子大学紀要, 59, 15-19. (2021).(査読なし)

中里隆之佑、飯泉恭一、佐々木啓、重永綾子、尾形慎、青木大地、三澤義知、細見修、久保原禅*
ヒト乳がん細胞の増殖と遺伝子発現に対する新規オリゴ糖MelNH2の効果.
順天堂スポーツ健康科学研究, 9(1), 1-10. (2018).(査読有)

久保原禅*
細胞性粘菌由来の生物活性物質DIF-1, DIF-2, DIF-3
和光純薬時報 80巻2号,2-6. (2012).(査読なし)

久保原禅*、桑山秀一
細胞性粘菌の細胞分化と走化性運動を制御する低分子化合物
生化学 82巻12号,1132-1137. (2010). (査読有)

<著書(2010年以降)>
桑山秀一、久保原禅(部分執筆)「走化性運動の分子機構」
『細胞性粘菌(研究の新展開)〜モデル生物、創薬資源、バイオ〜』(阿部知顕、前田靖男編、アイピーシー社刊)pp.217-238.全552頁 (2012年9月).

久保原禅(部分執筆)「柄細胞の分化」
『細胞性粘菌(研究の新展開)〜モデル生物、創薬資源、バイオ〜』(阿部知顕、前田靖男編、アイピーシー社刊)pp.351-374. 全552頁(2012年9月).

菊地晴久、久保原禅(部分執筆)「創薬資源としての細胞性粘菌」
『細胞性粘菌(研究の新展開)〜モデル生物、創薬資源、バイオ〜』(阿部知顕、前田靖男編、アイピーシー社刊)pp.485-510. 全552頁(2012年9月).

北村忠弘、北川浩史、穂坂正博、小島至 著、久保原禅 編著
『生活習慣病研究の最前線〜メタボ、老化、がん研究から、iPS細胞まで』ブックレット群馬大学⑨(上毛新聞社刊)全69頁 (2012年9月).

研究者 教育活動   ホームページURL